Javascript must be enabled for the correct page display
  • img
    search
    x
  • img
    CDMO Services
  • img
    TANVEX GLOBAL
  • img
    TWSE (6541) 51.90| $ TWD
  • About
    • Overview
    • Mission & Values
    • Our Journey
    • Leadership
    • Employee Stories
    Our mission is to make a positive contribution to humanity. We aim to improve the lives of people around the world by ensuring everyone has access to safe, effective, and affordable high-quality medicine — so they may live healthier days with their loved ones.
  • Products
    • Overview
    • Approved Products
    • Pipeline
    • Biosimilars
    • Pharmacovigilance
    We believe health is for everyone. We are building a pathway to help as many people as possible get access to safe, effective, and affordable high-quality medicine. Our products continue the fight against deadly diseases such as neutropenia and breast cancer.
  • News & Media
    • Press Releases
    • Media Resources
    Take a look at how we are impacting the world. Our news is your news as we continue our daily efforts to grant more patients access to safe, effective, and affordable high-quality medicine.
  • Resources
    • Brand to Biosimilar Database
    We aim to be a respected partner to our customers. We are proud to offer comprehensive patient support services designed to help simplify and support patient access — for every Tanvex product. And, as a service to the healthcare professionals we serve, Tanvex provides a live brand to biosimilar database for product reference purposes.
  • Careers
    • Why Tanvex
    • Benefits
    • Job Opportunities
    Come join our team. We are always looking for bright, motivated employees that share our vision to create a world where everyone has access to safe, effective, and affordable biopharmaceuticals.
  • Contact
    • GET IN TOUCH
    Reach out to us. We are ready to listen and help.
News

Take a look at how we are impacting the world.

All News

By Year:
  • Jan 19, 2025
    Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching New Era in Biologics Development
  • Sep 4, 2024
    Tanvex Appoints Biopharma Industry Veteran Stephen Lam as CEO
  • Aug 27, 2024
    Tanvex Forging Strategic Alliance with Bora Pharmaceuticals
  • Aug 19, 2024
    Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi™ and FDA Accepts Biosimilar Biologics License Application for TX-05
  • Aug 1, 2024
    FDA Accepts TX05 BLA Resubmission
preloader
1 2 3 NEXT
ALL NEWS
Follow Us
  • linkedin
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Return Goods Policy
  • Pharmacovigilance
  • Human Rights Statement
  • Labor Policy
  • Accessibility Statement